Multiple Sclerosis International Federation

 
 
News
Donate advanced search
print version print this page
 

inside
News:

 

  Sativex shows significant spasticity improvement
GW Pharmaceuticals has announced plans to submit an application to market its cannabis-based MS treatment, Sativex, in the UK.

To read more about this as reported by the UK MS Society click here.


Source: UK MS Society

Copyright &<br>Link Policy Copyright &
Link Policy
Privacy Policy Privacy Policy back to top
Disclaimer Disclaimer Acknowledgements Acknowledgements
back to top  back to top  
Email Update Email Update Edit User Details Edit User Details Feedback Feedback Glossary Glossary Site Map Site Map
Back to top Back to top